FOI release

reports/data of ADRs with glucose 50%

Case reference FOI2025/01285

Received 11 December 2025

Published 2 February 2026

Request

Due to the hypertonicity of 50% glucose, it is known that phlebitis and the like can occur.I am trying to review the use of this product within our trust and suggesting safer alternatives forhyperkalaemia.Do you have any data/numbers/reports on this please? A clinician is asking for any local, nationaldata to support or refute the need to change

Response

See attached

Documents

• FOI2025_01285 (redacted).pdf (880.6 KB)

This is Medicines and Healthcare products Regulatory Agency's response to a freedom of information (FOI) or environmental information regulations (EIR) request.

You can browse our other responses or make a new FOI request.